SPOTLIGHT: New bird flu strain emerges

The World Health Organization says that two Egyptians were infected by a new strain of bird flu that is resistant to Tamiflu. They don't know how the strain developed, but noted that it is worrying as Tamiflu remains the primary protection against the H5N1 version of avian flu. Report

Suggested Articles

Bristol Myers Squibb may have bounced Jounce from its roster of inherited partners, but it’s hanging onto Anokion, a Swiss autoimmune-focused biotech.

The priority review action date sets Bristol Myers up to win approval for the bluebird-partnered anti-BCMA CAR-T therapy in late March.

The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up.